Clovis Oncology, Inc. (CLVS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 AM ET
Company Participants
Anna Sussman - VP, IR
Patrick Mahaffy - President & CEO
Daniel Muehl - EVP & CFO
Conference Call Participants
Andrew Berens - SVB Leerink
Joe Catanzaro - Piper Sandler
Gavin Scott - JPMorgan
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Clovis Oncology Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions].
I would now like to hand the conference over to your speaker today, Anna Sussman, Vice President, Investor Relations. Thank you. Please go ahead.
Anna Sussman
Thank you, Tamia. Good morning, everyone, and welcome to the Clovis Oncology third quarter 2020 conference call. Thank you for joining us. You've likely seen this morning's news releases. If not, they're available on our website at clovisoncology.com.
As a reminder, this conference call is being recorded and webcast. Remarks may be accessed live on our website during the call and will be available in our archive for the next several weeks. Today's agenda includes the following: Pat Mahaffy, our President and CEO, will review the highlights of today's corporate update. Then Dan Muehl, Clovis' Chief Financial Officer, will cover the quarter's financial results in greater detail. Patrick will make a few closing remarks, and then we'll open the call for Q&A. During which time, Lindsey Rolfe, our Chief Medical Officer, will also be available to answer questions.
Some of our analysts have alerted us that today is a heavy reporting day for Q3 results. If you're unable to stay for Q&A and haven't already let us know, please send us an e-mail, and we'll set up the time to speak post-call.
- Read more current CLVSQ analysis and news
- View all earnings call transcripts